Network origin in John Aruny first degree
Entity | Entity type | Industry | |
---|---|---|---|
Vascular Access Society of The Americas
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Aruny via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ARTIVION, INC. | Medical Specialties | Corporate Officer/Principal | |
Pasadena City College | College/University | Undergraduate Degree | |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree | |
The Society of Thoracic Surgeons | Corporate Officer/Principal | ||
The International Society for Minimally Invasive Cardiac Surge | Corporate Officer/Principal | ||
American College of Cardiology Foundation
American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Medical/Nursing Services | Corporate Officer/Principal | |
Heart Valve Society of America
Heart Valve Society of America Medical/Nursing ServicesHealth Services The Heart Valve Society of America provides health care services. The non-profit company is based in New York, NY. | Medical/Nursing Services | Corporate Officer/Principal | |
American Association for Thoracic Surgery | Corporate Officer/Principal | ||
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
University of Vermont College of Medicine | College/University | Doctorate Degree | |
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. Medical SpecialtiesHealth Technology InnAVasc Medical, Inc. designs and develops products for vascular access for hemodialysis. Its technology vascular access graft is designed to create one contiguous flow lumen without transition points. The company is headquartered in Durham, NC. | Medical Specialties | Founder | |
HUMACYTE, INC. | Biotechnology | Director/Board Member | |
Kidney Health Initiative | Director/Board Member | ||
Foundation For Women & Girls With Blood Disorders | Director/Board Member | ||
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Biotechnology | Chief Executive Officer |
Statistics
International
United States | 16 |
Netherlands | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 4 |
Health Services | 3 |
Commercial Services | 2 |
Operational
Corporate Officer/Principal | 10 |
Director/Board Member | 6 |
Doctorate Degree | 3 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
William F. Northrup | 10 |
Jeffrey Lawson | 8 |
- Stock Market
- Insiders
- John Aruny
- Company connections